Literature DB >> 18402248

Glucose metabolism disorder in obese children assessed by continuous glucose monitoring system.

Chao-Chun Zou1, Li Liang, Fang Hong, Zheng-Yan Zhao.   

Abstract

BACKGROUND: Continuous glucose monitoring system (CGMS) can measure glucose levels at 5-minute intervals over a few days, and may be used to detect hypoglycemia, guide insulin therapy, and control glucose levels. This study was undertaken to assess the glucose metabolism disorder by CGMS in obese children.
METHODS: Eighty-four obese children were studied. Interstitial fluid (ISF) glucose levels were measured by CGMS for 24 hours covering the time for oral glucose tolerance test (OGTT). Impaired glucose tolerance (IGT), impaired fasting glucose (IFG), type 2 diabetic mellitus (T2DM) and hypoglycemia were assessed by CGMS.
RESULTS: Five children failed to complete CGMS test. The glucose levels in ISF measured by CGMS were highly correlated with those in capillary samples (r=0.775, P<0.001). However, the correlation between ISF and capillary glucose levels was lower during the first hour than that in the later time period (r=0.722 vs r=0.830), and the ISF glucose levels in 69.62% of children were higher than baseline levels in the initial 1-3 hours. In 79 obese children who finished the CGMS, 2 children had IFG, 2 had IGT, 3 had IFG + IGT, and 2 had T2DM. Nocturnal hypoglycemia was noted during the overnight fasting in 11 children (13.92%).
CONCLUSIONS: Our data suggest that glucose metabolism disorder including hyperglycemia and hypoglycemia is very common in obese children. Further studies are required to improve the precision of the CGMS in children.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18402248     DOI: 10.1007/s12519-008-0005-y

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  38 in total

1.  Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study.

Authors:  B W Bode; T M Gross; K R Thornton; J J Mastrototaro
Journal:  Diabetes Res Clin Pract       Date:  1999-12       Impact factor: 5.602

Review 2.  Does fall in tissue glucose precede fall in blood glucose?

Authors:  F Sternberg; C Meyerhoff; F J Mennel; H Mayer; F Bischof; E F Pfeiffer
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

3.  Continuous subcutaneous glucose monitoring in children with type 1 diabetes.

Authors:  H P Chase; L M Kim; S L Owen; T A MacKenzie; G J Klingensmith; R Murtfeldt; S K Garg
Journal:  Pediatrics       Date:  2001-02       Impact factor: 7.124

4.  Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus.

Authors:  Yariv Yogev; Rony Chen; Avi Ben-Haroush; Moshe Phillip; Lois Jovanovic; Moshe Hod
Journal:  Obstet Gynecol       Date:  2003-04       Impact factor: 7.661

5.  Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area.

Authors:  Tatsuhiko Urakami; Shigeki Kubota; Yoshikazu Nitadori; Kensuke Harada; Misao Owada; Teruo Kitagawa
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

6.  [Oral glucose tolerance and insulin release test in 52 cases of obese and overweight children].

Authors:  Wen-xin Sun; Wei Wang; De-fen Wang; Yi-fen Cui
Journal:  Zhonghua Er Ke Za Zhi       Date:  2005-02

7.  A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects.

Authors:  F R Kaufman; L C Gibson; M Halvorson; S Carpenter; L K Fisher; P Pitukcheewanont
Journal:  Diabetes Care       Date:  2001-12       Impact factor: 19.112

8.  [Obese children with benign acanthosis nigricans and insulin resistance: analysis of 19 cases].

Authors:  Jun-fen Fu; Li Liang; Guan-ping Dong; You-jun Jiang; Chao-chun Zou
Journal:  Zhonghua Er Ke Za Zhi       Date:  2004-12

9.  Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization.

Authors:  G Puavilai; S Chanprasertyotin; A Sriphrapradaeng
Journal:  Diabetes Res Clin Pract       Date:  1999-04       Impact factor: 5.602

10.  Insulin resistance contributes to obesity-related proteinuria.

Authors:  Hiroshi Matsumoto; Toshiyuki Nakao; Tomonari Okada; Yume Nagaoka; Hideaki Iwasawa; Ryo Tomaru; Toshikazu Wada
Journal:  Intern Med       Date:  2005-06       Impact factor: 1.271

View more
  5 in total

1.  Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data.

Authors:  Giada Acciaroli; Giovanni Sparacino; Liisa Hakaste; Andrea Facchinetti; Giorgio Maria Di Nunzio; Alessandro Palombit; Tiinamaija Tuomi; Rafael Gabriel; Jaime Aranda; Saturio Vega; Claudio Cobelli
Journal:  J Diabetes Sci Technol       Date:  2017-06-01

Review 2.  Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

Review 3.  Use of continuous glucose monitoring in obesity research: A scoping review.

Authors:  Elizabeth Hegedus; Sarah-Jeanne Salvy; Choo Phei Wee; Monica Naguib; Jennifer K Raymond; D Steven Fox; Alaina P Vidmar
Journal:  Obes Res Clin Pract       Date:  2021-09-02       Impact factor: 5.214

4.  Continuous glucose monitoring metrics for earlier identification of pre-diabetes: protocol for a systematic review and meta-analysis.

Authors:  Sara Gottfried; Laura Pontiggia; Andrew Newberg; Gregory Laynor; Daniel Monti
Journal:  BMJ Open       Date:  2022-08-25       Impact factor: 3.006

5.  Inflammation-Related Markers and Thyroid Function Measures in Pediatric Patients: Is the Grade of Obesity Relevant?

Authors:  Ioana Țaranu; Cecilia Lazea; Victoria Creț; Nicoleta Răcătăianu; Mihaela Iancu; Sorana D Bolboacă
Journal:  Diagnostics (Basel)       Date:  2021-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.